You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
To further enhance the quality of Future Pharmacology (ISSN: 2673-9879) and the papers published in it, under the guidance of our Editor-in-Chief, Prof. Dr. Fabrizio Schifano, the journal has updated and revised its aims. All new updates can be seen below:
Aims (new version): |
Aims (old version): |
Future Pharmacology (ISSN 2673-9879) is an international, peer-reviewed, open access journal on basic pharmacology, clinical pharmacology, drug discovery, and therapeutics published quarterly online by MDPI. It aims to achieve a better understanding and dissemination of pharmacological sciences. The journal focuses on publishing full research papers, reviews, and communications, but other article types will also be considered. Authors are encouraged to publish their results in as much detail as possible. Future Pharmacology will consider manuscripts within the field of complementary medicine or alternative medicine only if they are focused on pharmacological research. Regarding submissions involving natural products or chemical compounds, please see our Instructions for Authors for the requirements for natural product and chemical compound identification studies. Full experimental details must be provided so that the results can be reproduced. |
Future Pharmacology (ISSN 2673-9879) is an international, peer-reviewed, open access journal on basic pharmacology, clinical pharmacology, drug discovery, and therapeutics published quarterly online by MDPI. It aims to achieve a better understanding and dissemination of pharmacological sciences. The journal publishes full research papers, reviews, and communications. Authors are encouraged to publish their results in as much detail as possible. |
For more detailed information, please visit the following link: https://www.mdpi.com/journal/futurepharmacol/about.
Future Pharmacology Editorial Office